The Mayo Clinic CAR-T Cell Therapy Program is one of a few such landmark programs at select medical centers, with experts trained and certified to manage CAR-T cell therapy. Mayo Clinic was one of the centers that treated people as part of the clinical trial that led to FDA approval of CAR-T cell therapy.
CAR-T cell therapy may be a treatment option for:
- Relapsed, refractory B-cell acute lymphoblastic leukemia
- Relapsed, refractory B-cell non-Hodgkin's lymphoma
- Other types of cancer and medical conditions undergoing clinical studies
If you are eligible for CAR-T cell therapy at Mayo Clinic and scheduled for this treatment, you will undergo a process that takes many weeks.
Appointments. You will have many appointments and tests before and after CAR-T cell therapy. Depending on where you live, you may need to be away from home for periods of time throughout the CAR-T cell therapy process.
Caregivers. At least one other person should come with you to all of your appointments. A caregiver needs to stay with you 24 hours a day when you are not staying in the hospital during chemotherapy, infusion and care after infusion.
Treatment plan. Ongoing care may be needed for months to years after CAR-T cell therapy. During the CAR-T cell therapy process, your health may change in a way that infusing CAR-T cells may no longer be an option.